SCHEDULE: AWM Investment Discloses 9.99% Stake in Modular Medical

Sentiment:

Schedule 13G


AWM Investment Company, Inc. has filed a Schedule 13G reporting a 9.99% beneficial ownership stake in Modular Medical, Inc. common stock.

Summary

  • AWM Investment Company, Inc. reports beneficial ownership of 540,576 shares of Modular Medical, Inc. common stock.
  • The reported stake represents 9.99% of the company's total outstanding common shares.
  • The holdings consist of direct common shares, pre-funded warrants, and warrants adjusted for a 1-for-30 reverse stock split.
  • The reporting entity, AWM, acts as the investment adviser for four separate funds: Special Situations Cayman Fund, L.P., Special Situations Fund III QP, L.P., Special Situations Private Equity Fund, L.P., and Special Situations Life Sciences Fund, L.P.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine regulatory disclosure indicating institutional interest without signaling immediate strategic shifts or operational changes.

Positives

  • Institutional investor confidence indicated by a significant 9.99% equity position.
  • The investment is held in the ordinary course of business, suggesting a long-term investment strategy rather than an activist campaign.

Negatives

  • The ownership stake is heavily reliant on warrants, which may create future dilution for existing shareholders upon exercise.

Risks

  • Warrant exercise is capped at a 9.99% beneficial ownership threshold, limiting the immediate ability of the investor to increase their stake beyond this level.
  • The reliance on pre-funded and reverse-split adjusted warrants introduces complexity in calculating actual equity dilution.

Future Outlook

The filing does not provide specific forward-looking guidance regarding the company's operations, but confirms the investor's intent to hold the securities in the ordinary course of business without the purpose of changing or influencing control.

Management Comments

  • The reporting person certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that institutional filings of this nature are standard for small-cap medical device companies, often signaling that specialized investment firms are positioning themselves for potential long-term growth or liquidity events within the sector.

Comparison to Industry Standards

  • The 9.99% ownership threshold is a common 'block' position for institutional investors in small-cap equities to avoid triggering more stringent regulatory reporting requirements associated with 10%+ ownership.
  • The use of warrant-heavy structures is typical for capital-intensive medical technology firms seeking to manage cash flow while providing upside to early-stage investors.

Stakeholder Impact

  • Shareholders should note the potential for future dilution if the warrants held by AWM-advised funds are exercised.
  • The presence of a 9.99% holder provides a degree of institutional stability to the share register.

Next Steps

  • Continued monitoring of future SEC filings for any changes in the reporting person's ownership percentage or intent.

Key Dates

DateDescription
03/31/2026Date of event requiring the filing of the statement.
05/04/2026Date of signature by Adam Stettner, Executive Vice President of AWM Investment Company, Inc.

Keywords

Modular Medical, AWM Investment, Schedule 13G, Institutional Ownership, Equity Stake, Warrants, MODV

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.